UPDATE ON THE FAVOURABLE EFFECTS OF SITAGLIPTIN,DPP4 INHIBITOR ON PCOS

Dear my friends and fellow Colleagues, Here 8s an update on DPP4 Inhibitors. DPP-4 inhibitors found to decrease visceral adiposity and increase growth hormone half-life in PCOS women Reference https://www.medscape.com/viewarticle/923731_1 (Accession Date: May 11, 2020) Regards and thanks, Dr Sepuri Krishna Mohan.

3 Likes

LikeAnswersShare
Wonderful update as usual Dr Mohan. This trial was done with Sitagliptin, DPP4 Inhibitor. Usually the GH is low in PCOS which leads to increased VAT, Visceral Adiposity. Sitagliptin is shown to increase the GH and decrease the VAT which is a favourable effect in Patients suffering from PCOS, there by Sitagliptin lowers Blood Glucose levels in PCOS. Thanks again for a wonderful update Dr Mohan.
Valuable opinion
0
Great updates to learn from legendaris we are highly obliged This new update is very very encouraging and needful
Valuable opinion
0

View 3 other replies

Useful information and educative updated post. Thanks for sharing.
Thanks Dr Shivraj Agarwal
0

View 1 other reply

@Dr Dineshchandra Sharma Dear Guru jee, Your valuable feedback and suggestions are very much required in this context as you are the pioneer in REPRODUCTORY ENDOCRINOLOGY in INDIA.
Wow, excellent update for the obg people.
Valuable opinion
0

Cases that would interest you